BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luzi L, Perseghin G, Tambussi G, Meneghini E, Scifo P, Pagliato E, Del Maschio A, Testolin G, Lazzarin A. Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy. Am J Physiol Endocrinol Metab 2003;284:E274-80. [PMID: 12388139 DOI: 10.1152/ajpendo.00391.2001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Torriani M, Thomas BJ, Halpern EF, Jensen ME, Rosenthal DI, Palmer WE. Intramyocellular lipid quantification: repeatability with 1H MR spectroscopy. Radiology 2005;236:609-14. [PMID: 16040916 DOI: 10.1148/radiol.2362041661] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
2 Balasubramanyam A, Sekhar RV, Jahoor F, Jones PH, Pownall HJ. Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of ‘systemic steatosis’. Curr Opin Lipidol. 2004;15:59-67. [PMID: 15166810 DOI: 10.1097/00041433-200402000-00011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
3 Fève B, Glorian M, Hadri KE. Pathophysiology of the HIV-Associated Lipodystrophy Syndrome. Metab Syndr Relat Disord 2004;2:274-86. [PMID: 18370696 DOI: 10.1089/met.2004.2.274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
4 Lattuada G, Costantino F, Caumo A, Scifo P, Ragogna F, De Cobelli F, Del Maschio A, Luzi L, Perseghin G. Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients. Diabetologia 2005;48:741-7. [DOI: 10.1007/s00125-005-1686-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
5 Cade WT, Reeds DN, Mittendorfer B, Patterson BW, Powderly WG, Klein S, Yarasheski KE. Blunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAART. Am J Physiol Endocrinol Metab 2007;292:E812-9. [PMID: 17106066 DOI: 10.1152/ajpendo.00300.2006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
6 Kosmiski LA, Ringham BM, Grunwald GK, Bessesen DH. Dual-energy X-ray absorptiometry modeling to explain the increased resting energy expenditure associated with the HIV lipoatrophy syndrome. Am J Clin Nutr 2009;90:1525-31. [PMID: 19828707 DOI: 10.3945/ajcn.2009.28103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
7 Natsag J, Erlandson KM, Sellmeyer DE, Haberlen SA, Margolick J, Jacobson LP, Palella FJ Jr, Koletar SL, Lake JE, Post WS, Brown TT. HIV Infection Is Associated with Increased Fatty Infiltration of the Thigh Muscle with Aging Independent of Fat Distribution. PLoS One 2017;12:e0169184. [PMID: 28060856 DOI: 10.1371/journal.pone.0169184] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
8 Perseghin G, Lattuada G, Danna M, Sereni LP, Maffi P, De Cobelli F, Battezzati A, Secchi A, Del Maschio A, Luzi L. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab. 2003;285:E1174-E1181. [PMID: 12933352 DOI: 10.1152/ajpendo.00279.2003] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 5.7] [Reference Citation Analysis]
9 Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E. HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact. AIDS Res Ther 2007;4:16. [PMID: 17634130 DOI: 10.1186/1742-6405-4-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
10 Torriani M, Hadigan C, Jensen ME, Grinspoon S. Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome. Journal of Applied Physiology 2003;95:1005-10. [DOI: 10.1152/japplphysiol.00366.2003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 2.5] [Reference Citation Analysis]
11 Richmond SR, Carper MJ, Lei X, Zhang S, Yarasheski KE, Ramanadham S. HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters. Biochim Biophys Acta 2010;1801:559-66. [PMID: 20117238 DOI: 10.1016/j.bbalip.2010.01.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
12 Koethe JR. Adipose Tissue in HIV Infection. Compr Physiol 2017;7:1339-57. [PMID: 28915327 DOI: 10.1002/cphy.c160028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
13 Machann J, Häring H, Schick F, Stumvoll M. Intramyocellular lipids and insulin resistance. Diabetes Obes Metab 2004;6:239-48. [PMID: 15171747 DOI: 10.1111/j.1462-8902.2004.00339.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 101] [Article Influence: 6.3] [Reference Citation Analysis]
14 Njuguna B, Kiplagat J, Bloomfield GS, Pastakia SD, Vedanthan R, Koethe JR. Prevalence, Risk Factors, and Pathophysiology of Dysglycemia among People Living with HIV in Sub-Saharan Africa. J Diabetes Res. 2018;2018:6916497. [PMID: 30009182 DOI: 10.1155/2018/6916497] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
15 Pérez-Matute P, Pérez-Martínez L, Blanco JR, Ibarra V, Metola L, Sanz M, Hernando L, Martínez S, Ramírez A, Ramalle-Gomara E, Oteo JA. Multiple frequency bioimpedance is an adequate tool to assess total and regional fat mass in HIV-positive patients but not to diagnose HIV-associated lipoatrophy: a pilot study. J Int AIDS Soc 2013;16:18609. [PMID: 24378223 DOI: 10.7448/IAS.16.1.18609] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
16 Dobbins RL, Malloy CR. Measuring in-vivo metabolism using nuclear magnetic resonance. Curr Opin Clin Nutr Metab Care. 2003;6:501-509. [PMID: 12913667 DOI: 10.1097/00075197-200309000-00003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
17 Erion DM, Shulman GI. Diacylglycerol-mediated insulin resistance. Nat Med. 2010;16:400-402. [PMID: 20376053 DOI: 10.1038/nm0410-400] [Cited by in Crossref: 294] [Cited by in F6Publishing: 281] [Article Influence: 24.5] [Reference Citation Analysis]
18 Boschmann M, Engeli S, Moro C, Luedtke A, Adams F, Gorzelniak K, Rahn G, Mähler A, Dobberstein K, Krüger A, Schmidt S, Spuler S, Luft FC, Smith SR, Schmidt HH, Jordan J. LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J Clin Endocrinol Metab 2010;95:1634-43. [PMID: 20130076 DOI: 10.1210/jc.2009-1293] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
19 Nzuza S, Zondi S, Owira PMO. Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo. PLoS One 2017;12:e0183355. [PMID: 29121676 DOI: 10.1371/journal.pone.0183355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Fitch K, Abbara S, Lee H, Stavrou E, Sacks R, Michel T, Hemphill L, Torriani M, Grinspoon S. Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome. AIDS 2012;26:587-97. [PMID: 22112605 DOI: 10.1097/QAD.0b013e32834f33cc] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
21 Scherzer R, Shen W, Heymsfield SB, Lewis CE, Kotler DP, Punyanitya M, Bacchetti P, Shlipak MG, Grunfeld C; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Intermuscular adipose tissue and metabolic associations in HIV infection. Obesity (Silver Spring) 2011;19:283-91. [PMID: 20539305 DOI: 10.1038/oby.2010.115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Driscoll SD, Meininger GE, Ljungquist K, Hadigan C, Torriani M, Klibanski A, Frontera WR, Grinspoon S. Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 2004;89:2171-8. [PMID: 15126538 DOI: 10.1210/jc.2003-031858] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
23 Tsiodras S, Kelesidis T, Mantzoros CS. The HAART-Induced Metabolic Syndrome. In: Mantzoros CS, editor. Obesity and Diabetes. Totowa: Humana Press; 2006. pp. 403-26. [DOI: 10.1007/978-1-59259-985-1_23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Hadigan C, Kamin D, Liebau J, Mazza S, Barrow S, Torriani M, Rubin R, Weise S, Fischman A, Grinspoon S. Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy. Am J Physiol Endocrinol Metab 2006;290:E289-98. [PMID: 16131513 DOI: 10.1152/ajpendo.00273.2005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
25 Hadigan C, Liebau J, Torriani M, Andersen R, Grinspoon S. Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia. J Clin Endocrinol Metab. 2006;91:4438-4444. [PMID: 16940448 DOI: 10.1210/jc.2006-1174] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
26 Haugaard SB, Andersen O, Dela F, Holst JJ, Storgaard H, Fenger M, Iversen J, Madsbad S. Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic β-cells. eur j endocrinol 2005;152:103-12. [DOI: 10.1530/eje.1.01835] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
27 Harvey I, Boudreau A, Stephens JM. Adipose tissue in health and disease. Open Biol 2020;10:200291. [PMID: 33292104 DOI: 10.1098/rsob.200291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
28 Haugaard SB. Toxic metabolic syndrome associated with HAART. Expert Opinion on Drug Metabolism & Toxicology 2006;2:429-45. [DOI: 10.1517/17425255.2.3.429] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
29 Lien LF, Feinglos MN. Protease inhibitor-induced diabetic complications : incidence, management and prevention. Drug Saf 2005;28:209-26. [PMID: 15733026 DOI: 10.2165/00002018-200528030-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
30 Pennisi EM, Garibaldi M, Antonini G. Lipid Myopathies. J Clin Med 2018;7:E472. [PMID: 30477112 DOI: 10.3390/jcm7120472] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
31 Torriani M, Thomas BJ, Barlow RB, Librizzi J, Dolan S, Grinspoon S. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution. J Appl Physiol (1985) 2006;100:609-14. [PMID: 16223978 DOI: 10.1152/japplphysiol.00797.2005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
32 Lindegaard B, Hvid T, Wolsk Mygind H, Mortensen OH, Grøndal T, Abildgaard J, Gerstoft J, Pedersen BK, Baranowski M. Low expression of IL-18 and IL-18 receptor in human skeletal muscle is associated with systemic and intramuscular lipid metabolism-Role of HIV lipodystrophy. PLoS One 2018;13:e0186755. [PMID: 29342149 DOI: 10.1371/journal.pone.0186755] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
33 Villarroya F, Domingo P, Giralt M. Drug-induced lipotoxicity: Lipodystrophy associated with HIV-1 infection and antiretroviral treatment. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2010;1801:392-9. [DOI: 10.1016/j.bbalip.2009.09.018] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
34 Fleischman A, Johnsen S, Systrom DM, Hrovat M, Farrar CT, Frontera W, Fitch K, Thomas BJ, Torriani M, Côté HC, Grinspoon SK. Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. Am J Physiol Endocrinol Metab 2007;292:E1666-73. [PMID: 17284576 DOI: 10.1152/ajpendo.00550.2006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 101] [Article Influence: 7.0] [Reference Citation Analysis]
35 Hruz PW. HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models. Curr Opin HIV AIDS 2008;3:660-5. [PMID: 19373039 DOI: 10.1097/COH.0b013e3283139134] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
36 Benedini S, Luzi L. Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy? J Transl Int Med 2016;4:150-4. [PMID: 28191538 DOI: 10.1515/jtim-2016-0026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
37 Robinson-Papp J, Tan IL, Simpson DM. Neuromuscular complications in HIV: effects of aging. J Neurovirol 2012;18:331-8. [PMID: 22207585 DOI: 10.1007/s13365-011-0074-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
38 Kosmiski LA, Bessesen DH, Stotz SA, Koeppe JR, Horton TJ. Short-term energy restriction reduces resting energy expenditure in patients with HIV lipodystrophy and hypermetabolism. Metabolism 2007;56:289-95. [DOI: 10.1016/j.metabol.2006.10.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
39 Haugaard S, Andersen O, Pedersen S, Dela F, Deacon C, Holst J, Iversen J, Madsbad S. Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy. HIV Med 2006;7:163-72. [DOI: 10.1111/j.1468-1293.2006.00364.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
40 Vassimon HS, de Paula FJ, Machado AA, Monteiro JP, Jordão AA Jr. Hypermetabolism and altered substrate oxidation in HIV-infected patients with lipodystrophy. Nutrition 2012;28:912-6. [PMID: 22503533 DOI: 10.1016/j.nut.2011.12.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
41 Anderson N, Borlak J. Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis. Pharmacol Rev 2008;60:311-57. [DOI: 10.1124/pr.108.00001] [Cited by in Crossref: 260] [Cited by in F6Publishing: 249] [Article Influence: 18.6] [Reference Citation Analysis]
42 Chaudhary NS, Kind T, Willig AL, Saag MS, Shrestha S, Funderburg N, Wiener HW, Overton ET, Irvin MR. Changes in lipidomic profile by anti-retroviral treatment regimen: An ACTG 5257 ancillary study. Medicine (Baltimore) 2021;100:e26588. [PMID: 34397689 DOI: 10.1097/MD.0000000000026588] [Reference Citation Analysis]
43 Reeds DN, Yarasheski KE, Fontana L, Cade WT, Laciny E, DeMoss A, Patterson BW, Powderly WG, Klein S. Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia. Am J Physiol Endocrinol Metab 2006;290:E47-53. [PMID: 16118251 DOI: 10.1152/ajpendo.00236.2005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
44 Herrero P, Gropler RJ. Imaging of myocardial metabolism. J Nucl Cardiol 2005;12:345-58. [PMID: 15944540 DOI: 10.1016/j.nuclcard.2005.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
45 Ngala RA, Fianko K. Dyslipidaemia and dysglycaemia in HIV-infected patients on highly active anti-retroviral therapy in Kumasi Metropolis. Afr Health Sci 2013;13:1107-16. [PMID: 24940339 DOI: 10.4314/ahs.v13i4.35] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
46 Manini TM, Clark BC, Nalls MA, Goodpaster BH, Ploutz-Snyder LL, Harris TB. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr 2007;85:377-84. [PMID: 17284732 DOI: 10.1093/ajcn/85.2.377] [Cited by in Crossref: 183] [Cited by in F6Publishing: 177] [Article Influence: 12.2] [Reference Citation Analysis]
47 Hadigan C, Liebau J, Andersen R, Holalkere NS, Sahani DV. Magnetic resonance spectroscopy of hepatic lipid content and associated risk factors in HIV infection. J Acquir Immune Defic Syndr. 2007;46:312-317. [PMID: 17721396 DOI: 10.1097/qai.0b013e3181568cc2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
48 Hruz PW. Molecular mechanisms for insulin resistance in treated HIV-infection. Best Pract Res Clin Endocrinol Metab 2011;25:459-68. [PMID: 21663839 DOI: 10.1016/j.beem.2010.10.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
49 Phillips PS, Haas RH. Statin myopathy as a metabolic muscle disease. Expert Rev Cardiovasc Ther 2008;6:971-8. [PMID: 18666847 DOI: 10.1586/14779072.6.7.971] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
50 Bourgi K, Wanjalla C, Koethe JR. Inflammation and Metabolic Complications in HIV. Curr HIV/AIDS Rep 2018;15:371-81. [PMID: 30058057 DOI: 10.1007/s11904-018-0411-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]